2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- PMID: 34447992
- DOI: 10.1093/eurheartj/ehab368
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Erratum in
-
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.Eur Heart J. 2021 Dec 21;42(48):4901. doi: 10.1093/eurheartj/ehab670. Eur Heart J. 2021. PMID: 34649282 No abstract available.
Keywords: advanced heart failure; transplantation; Guidelines; acute heart failure; arrhythmias; cardiac resynchronization therapy; comorbidities; diagnosis; ejection fraction; heart failure; hospitalization; mechanical circulatory support; multidisciplinary management; natriuretic peptides; neuro-hormonal antagonists; pharmacotherapy.
Comment in
-
The fastest way to the heart is through the veins: towards a better understanding of congestion.Eur J Heart Fail. 2022 Mar;24(3):463-465. doi: 10.1002/ejhf.2442. Epub 2022 Feb 14. Eur J Heart Fail. 2022. PMID: 35118776 No abstract available.
Similar articles
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592. Epub 2016 May 20. Eur J Heart Fail. 2016. PMID: 27207191 No abstract available.
-
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20. Eur Heart J. 2016. PMID: 27206819 No abstract available.
-
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail. 2022 Jan;24(1):4-131. doi: 10.1002/ejhf.2333. Eur J Heart Fail. 2022. PMID: 35083827
-
Is cardiac resynchronization therapy an option in heart failure patients with preserved ejection fraction? Justification for the ongoing KaRen project.Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):404-10. doi: 10.1016/j.acvd.2010.01.009. Epub 2010 Jun 23. Arch Cardiovasc Dis. 2010. PMID: 20800804 Review.
-
[Acute and chronic heart failure in light of the new ESC guidelines].Herz. 2013 Dec;38(8):812-20. doi: 10.1007/s00059-013-3986-9. Herz. 2013. PMID: 24146139 Review. German.
Cited by
-
Predictive Value of Monocyte-To-Lymphocyte Ratio in Differentiating Heart Failure with Reduced Ejection Fraction in Patients with Severe Aortic Stenosis-A Retrospective Analysis.J Clin Med. 2024 Oct 19;13(20):6249. doi: 10.3390/jcm13206249. J Clin Med. 2024. PMID: 39458199 Free PMC article.
-
Preventing Cancer Therapy-Related Cardiotoxicity: Should We be PROACTive or Reactive?JACC CardioOncol. 2024 Oct 15;6(5):697-698. doi: 10.1016/j.jaccao.2024.09.001. eCollection 2024 Oct. JACC CardioOncol. 2024. PMID: 39479315 Free PMC article.
-
Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis.Front Cardiovasc Med. 2022 Sep 20;9:937291. doi: 10.3389/fcvm.2022.937291. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36204571 Free PMC article.
-
Improved Interpretation of Pulmonary Artery Wedge Pressures through Left Atrial Volumetry-A Cardiac Magnetic Resonance Imaging Study.J Cardiovasc Dev Dis. 2024 Jun 11;11(6):178. doi: 10.3390/jcdd11060178. J Cardiovasc Dev Dis. 2024. PMID: 38921678 Free PMC article.
-
The Effect of Tolvaptan on Metabolism and Electrolyte Homeostasis in Patients with Heart Failure: A Systematic Review and Meta-Analysis.Rev Cardiovasc Med. 2024 Sep 19;25(9):334. doi: 10.31083/j.rcm2509334. eCollection 2024 Sep. Rev Cardiovasc Med. 2024. PMID: 39355601 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical